#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Phase 2 Study of Lirafugratinib in Patients with Previously Treated Unresectable Advanced Solid Tumors with FGFR2 Fusion (Excluding Cholangiocarcinoma)

    Not yet recruiting

    2 1 1
    France Spain

  • A study to evaluate the safety of SGN-ALPV in patients with advanced solid tumors

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark The Netherlands Spain Sweden

  • Study Comparing Chemotherapy Alone to Dostarlimab, Paclitaxel, and Carboplatin for Patients with Advanced or Metastatic Endometrial Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Romania Spain

  • Study of Disitamab Vedotin for Adults with Previously Treated HER2-Positive Solid Tumors, Including Lung, Head and Neck, Ovarian, and Endometrial Cancers

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    France Germany Italy Spain

  • A study comparing how lenvatinib capsules are absorbed in the body in healthy volunteers under fasting and fed conditions

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Portugal

  • Study on Raludotatug Deruxtecan for Patients with Advanced or Metastatic Solid Tumors, Including Gynecological and Genitourinary Cancers

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark France Italy Spain

  • Study of Fadraciclib in Adults with Advanced Solid Tumors (Including Breast, Colorectal, Endometrial, Ovarian, Biliary Tract, and Liver Cancer) and Lymphoma

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study Comparing Sentinel Node Policy with Current Staging Protocols in Early Stage Endometrial Cancer Using Patent Blue, Technetium (99mTc) Rheniumsulfide, and Indocyanine Green

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    France

  • Study on Durvalumab, Paclitaxel, Carboplatin, and Olaparib for Patients with Advanced or Recurrent Endometrial Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    Belgium Estonia Germany Greece Hungary Lithuania +2

  • Study of NP137 with carboplatin, paclitaxel and pembrolizumab combination therapy for patients with advanced endometrial or cervical cancer who had prior chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France